Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Patented Medicine Prices Review Board (PMPRB) in Active Registrations on: 2024-02-29

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

Results 1-50 of 126

  • Québec Association of Pharmacy Distributors / Association québécoise des distributeurs en pharmacie
    Consultant: Hugues Mousseau, Heyco Advisory Services Inc. / Cabinet conseil Heyco inc.
    Posted date: 2024-05-16
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: GERALD JEFFCOTT, 3Sixty Public Affairs
    Posted date: 2024-05-06
    Submission type: Update View updated registration
  • Canadian Medical Association / Association médicale canadienne
    In-house Organization: Timothy Smith, Chief Executive Officer
    Posted date: 2024-03-15
    Submission type: Update View updated registration
  • Canadian Medical Association / Association médicale canadienne
    Consultant (Member of the board of directors) (Member of the organization): Kathleen Ross
    Posted date: 2024-03-15
    Submission type: Update View updated registration
  • Canadian Medical Association / Association médicale canadienne
    Consultant (Member of the board of directors) (Member of the organization): Joss Reimer
    Posted date: 2024-03-15
    Submission type: Update View updated registration
  • Canadian Medical Association / Association médicale canadienne
    Consultant (Member of the board of directors) (Member of the organization): Jean-Joseph Conde
    Posted date: 2024-03-15
    Submission type: Update View updated registration
  • Canadian Medical Association / Association médicale canadienne
    Consultant (Member of the board of directors) (Member of the organization): Alika Lafontaine
    Posted date: 2024-03-15
    Submission type: Update View updated registration
  • The Canada Life Assurance Company / de la Compagnie d'Assurance du Canada sur la Vie
    In-house Corporation: Paul Mahon, President and Chief Executive Officer
    Posted date: 2024-03-14
    Submission type: Update View updated registration
  • Canadian Life and Health Insurance Association Inc. / Association canadienne des compagnies d'assurances de personnes inc.
    In-house Organization: Stephen Frank, President and Chief Executive Officer
    Posted date: 2024-03-13
    Submission type: Update View updated registration
  • Food, Health & Consumer Products of Canada / Produits alimentaires, de santé et de consommation du Canada
    In-house Organization: Michael Graydon, Chief Executive Officer
    Posted date: 2024-02-29
    Submission type: Update View updated registration
  • AbbVie Corporation
    In-house Corporation: RAMI FAYED, Vice President and General Manager, Canada
    Posted date: 2024-02-28
    Submission type: Update View updated registration
  • Sanofi Pasteur Limited
    In-house Corporation: Matthieu Puyet, Head of Manufacturing & Supply, Canada, Toronto Site Head
    Posted date: 2024-02-27
    Submission type: Update View updated registration
  • Cystic Fibrosis Canada / Fibrose kystique Canada
    In-house Organization: Kelly Grover, President and Chief Executive Officer
    Posted date: 2024-02-20
    Submission type: Update View updated registration
  • Familiprix inc.
    In-house Corporation: Albert Falardeau, Président
    Posted date: 2024-02-20
    Submission type: Update View updated registration
  • Sandoz Canada Inc.
    In-house Corporation: Michel Robidoux, President & Chief Executive Officer
    Posted date: 2024-02-19
    Submission type: Update View updated registration
  • IQVIA Solutions Canada Inc.
    In-house Corporation: Sylvia Durgerian, President
    Posted date: 2024-02-19
    Submission type: Update View updated registration
  • Takeda Canada
    Consultant: Don Boudria, Don Boudria Consulting Inc
    Posted date: 2024-02-16
    Submission type: Update View updated registration
  • Life Sciences Ontario (LSO)
    In-house Corporation: Jason Field, President & CEO
    Posted date: 2024-02-16
    Submission type: Update View updated registration
  • GlaxoSmithKline
    In-house Corporation: Sridhar Venkatesh, General Manager and President
    Posted date: 2024-02-16
    Submission type: Update View updated registration
  • CANADIAN CANCER SOCIETY / Société canadienne du cancer
    In-house Organization: Andrea Seale, Chief Executive Officer
    Posted date: 2024-02-15
    Submission type: Update View updated registration
  • MS Canada / SP Canada
    In-house Organization: Pamela Valentine, President & CEO
    Posted date: 2024-02-15
    Submission type: Update View updated registration
  • Amgen Canada Inc.
    In-house Corporation: Ugur Gunaydin, General Manager, Canada
    Posted date: 2024-02-14
    Submission type: Update View updated registration
  • GHGSat Inc.
    Consultant: Lucas Borchenko, Crestview Strategy
    Posted date: 2024-02-12
    Submission type: New View new registration
  • HealthCareCAN / SoinsSantéCAN
    In-house Organization: Paul-Émile Cloutier, President and Chief Executive Officer (CEO)
    Posted date: 2024-02-09
    Submission type: Update View updated registration
  • Eli Lilly Canada Inc.
    In-house Corporation: Kenneth L Custer, President and General Manager
    Posted date: 2024-02-09
    Submission type: Update View updated registration
  • Canadian Organization for Rare Disorders
    Consultant: Emily Bowes, 3Sixty Public Affairs Inc.
    Posted date: 2024-02-08
    Submission type: New View new registration
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation: Mark Vineis, Country President
    Posted date: 2024-02-07
    Submission type: Update View updated registration
  • GlaxoSmithKline Inc.
    Consultant: Alexander MacDonald, Counsel Public Affairs Inc.
    Posted date: 2024-02-07
    Submission type: New View new registration
  • Association québécoise des distributeurs en pharmacie
    In-house Organization: Albert Falardeau, Président
    Posted date: 2024-02-01
    Submission type: Update View updated registration
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation: Michael Siauw, General Manager – Canada
    Posted date: 2024-02-01
    Submission type: Update View updated registration
  • Hoffmann-La Roche Limited
    In-house Corporation: BRIGITTE NOLET, PRESIDENT AND CHIEF EXECUTIVE OFFICER
    Posted date: 2024-01-24
    Submission type: Update View updated registration
  • Best Medicines Coalition / Coalition pour de meilleurs médicaments
    Consultant: Jay Strauss
    Posted date: 2024-01-11
    Submission type: Update View updated registration
  • Doctors without Borders (MSF) Canada / Médecins sans Frontières (MSF) Canada
    In-house Organization: Sarah Lamb, Interim Executive Director
    Posted date: 2024-01-10
    Submission type: Update View updated registration
  • Best Medicines Coalition / Coalition pour de meilleurs médicaments
    Consultant: Paulette Eddy
    Posted date: 2024-01-10
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2024-01-09
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: Stephanie Levee, 3Sixty Public Affairs Inc.
    Posted date: 2024-01-09
    Submission type: Update View updated registration
  • McKesson Canada
    In-house Corporation: Joan Eliasek, President
    Posted date: 2024-01-08
    Submission type: Update View updated registration
  • Canadian Pharmacists Association / Association des Pharmaciens du Canada
    In-house Organization: Glen Doucet, Chief Executive Officer
    Posted date: 2024-01-02
    Submission type: Update View updated registration
  • Key DH Technologies
    Consultant: Michael Friesen, Global Public Affairs Inc
    Posted date: 2024-01-02
    Submission type: Update View updated registration
  • Key DH Technologies
    Consultant: Ted Gruetzner, Global Public Affairs
    Posted date: 2024-01-02
    Submission type: Update View updated registration
  • Bausch Health, Canada Inc. / Bausch Health, Canada Inc. Solutions de Sante
    In-house Organization: Cees Heiman, General Manager and President
    Posted date: 2023-12-22
    Submission type: Update View updated registration
  • Gilead Sciences Canada
    In-house Corporation: Christophe Griolet, V.P. and General Manager
    Posted date: 2023-12-22
    Submission type: Update View updated registration
  • Janssen Inc.
    In-house Corporation: Berkeley Vincent, President
    Posted date: 2023-12-15
    Submission type: Update View updated registration
  • Gilead Sciences Canada Inc.
    Consultant: Greg Maceachern, KAN Strategies
    Posted date: 2023-12-15
    Submission type: Update View updated registration
  • Innovative Medicines Canada / Médicaments novateurs Canada
    Consultant: William Shelling, Counsel Public Affairs Inc.
    Posted date: 2023-12-14
    Submission type: New View new registration
  • Innovative Medicines Canada / Médicaments novateurs Canada
    Consultant: Mike Ras, Counsel Public Affairs Inc.
    Posted date: 2023-12-14
    Submission type: New View new registration
  • Innovative Medicines Canada
    Consultant: John Delacourt, Counsel Public Affairs
    Posted date: 2023-12-13
    Submission type: Reactivation View reactivated registration
  • Innovative Medicines Canada / Médicaments novateurs Canada
    Consultant: Alexander MacDonald, Counsel Public Affairs Inc.
    Posted date: 2023-12-13
    Submission type: New View new registration
  • Innovative Medicines Canada / Médicaments novateurs Canada
    Consultant: BRAD LAVIGNE, Counsel Public Affairs Inc.
    Posted date: 2023-12-13
    Submission type: New View new registration
  • Innovative Medicines Canada / Médicaments novateurs Canada
    Consultant: Ben Parsons, Counsel Public Affairs Inc.
    Posted date: 2023-12-13
    Submission type: New View new registration
Return to Government Institutions in Active Registrations
Date Modified: